Origin
Science
as a
starting point.
Most supplement brands start with a market gap. FOOON started with a decade inside molecular research — and a growing frustration that the science rarely made it into the products people were actually using.
Dr Periklis
Katopodis
Molecular Oncologist
Founder & CEO, FOOON
"I wanted to build the kind of products I couldn't find when I needed them most — made properly, priced honestly, and worth trusting."
From MSc to PostDoc, the research spanned liquid biopsy development, molecular diagnostics, and clinical and pharmaceutical environments. That work builds a specific way of thinking about evidence — and a low tolerance for formulations that don't hold up to scrutiny.
The frustration was straightforward: liposomal delivery works. The absorption data is clear and well-documented. But the products that used it were inconsistent, opaque, or priced beyond reach — particularly for the people who needed them most.
FOOON is the product of that frustration made useful. Every formulation is built the way a researcher builds it — with a clear rationale, transparent ingredients, and no interest in shortcuts.
A decade in molecular oncology
The research spanned liquid biopsy, molecular diagnostics, and clinical environments — building a precise, evidence-driven standard that shaped how every FOOON formulation is evaluated and built.
The science wasn't reaching the products
Liposomal delivery is well-supported in literature. But the products using it were inconsistent, opaque, or inaccessible for the people — working professionals, students, anyone under sustained cognitive load — who needed them most.
Build the thing that should exist
FOOON is the direct result of that frustration made useful. Formulated with a documented rationale, transparent ingredients, and manufactured in an FDA-registered facility — not because it makes a nice story, but because it's the only way to do it properly.
"I wanted to build the kind of products I couldn't find when I needed them most — made properly, priced honestly, and worth trusting."
- Τailored Glucocorticoid Therapy in Assisted Reproduction: Benefits for RIF Patients and Women with Immunological Dysregulation (2026)
- Improving IVF Outcomes in Endometriosis Patients- from Pharmacological Suppression to Endometrial Adjuvants (2026)
- Extracellular Matrix Remodeling and Matrix Metalloproteinases in Ovarian Function and Infertility. International Journal of Molecular Sciences (2026)
- Molecular Mechanisms of Dysregulated LH and FSH Secretion in Human Reproductive Failure. Biomedicines (2026)
- Leptin Receptor (LEPR) Mutations Disrupt Hypothalamic Control of the Reproductive Axis. International Journal of Molecular Sciences (2026)
- Genetic and Epigenetic Risks of Male Infertility in ART. International Journal of Molecular Sciences (2025)
- Reproductive Health and Assisted Conception in Celiac Disease and Non-Celiac Gluten Sensitivity: A Narrative Review. Nutrients (2025)
- Gut Microbiome Dysbiosis and Its Impact on Reproductive Health: Mechanisms and Clinical Applications. Metabolites (2025)
- Dietary and Lifestyle Interventions to Mitigate Oxidative Stress in Male and Female Fertility: Practical Insights for Infertility Management - A Narrative Review. Metabolites (2025)
- Oxidative Stress and the NLRP3 Inflammasome: Focus on Female Fertility and Reproductive Health. Cells (2025)
- Impact of Reductive Stress on Human Infertility: Underlying Mechanisms and Perspectives. International Journal of Molecular Sciences (2024)
- Impact of anaesthesia on perioperative inflammation in patients undergoing lung cancer resection. Journal of Cardiothorasic and Vascular Anesthesia (2023)
- Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs. Molecular medicine reports (2022)
- Differential expression of RAD51AP1 at protein level in ovarian cancer: effects of siRNA in vitro. Journal of Personalized Medicine (2022)
- Acid-base abnormalities and liver dysfunction. Annals of Hepatology (2022)
- Host cell entry mediators implicated in the cellular tropism of SARS-CoV-2 and the pathophysiology of COVID-19 and identification of microRNAs that can modulate their expression. International Journal of Molecular Medicine (2021)
- Circulating tumour cells and circulating cell-free DNA in lung cancer patients: A comparison between Thoracotomy and Video-Assisted Thoracoscopic Surgery. BMJ Open Respiratory Research (2021)
- p38β - MAPK11 and its role in female cancers. Journal of Ovarian Research (2021)
- COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease. International Journal of Molecular Medicine (2021)
- Patient’s satisfactory outcomes after implementation of follow up “virtual clinic” in age related macular degeneration treatment. Clinical and Experimental Optometry (2021)
- Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID. International Journal of Oncology (2020)
- Pathophysiology of Drug-induced Hypomagnesemia. Drug Safety (2020)
- Image analysis of 3D conjunctival melanoma cell cultures following electrochemotherapy. Biomedicines (2020)
- Endometrial changes in estrogen and progesterone receptor expression during implantation in an oocyte donation program. Experimental and therapeutic medicine (2020)
- Molecular characteristics of Uveal Melanoma and intraocular tumors. Oncology reports (2020)
- In silico and in vitro analysis of lncRNA XIST reveals a panel of possible lung cancer regulators and a five-gene diagnostic signature. Cancers (2020)
- Kinase inhibitors in ovarian cancer. Cancers (2019)
- The Effect of Dialysis Modality and Membrane Performance on Native Immunity in Dialysis Patients. Prilozi (2019)
- Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications. Cancers (2019)
- Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro. Neoplasma (2018)
- Conjunctival Melanoma and Electrochemotherapy: Preliminary results using 2D and 3D cell culture models in vitro. Acta Ophthalmologica (2018)
- Adipophilin expression in primary and metastatic uveal melanoma: a pilot study. Graefe's archive for clinical and experimental ophthalmology (2017)